Saturday, September 23, 2023
Saturday, September 23, 2023

Northwell Direct to Provide Telehealth Services to U.S. Department of State

Northwell Direct today announced that it has been selected as the subcontractor on a U.S. Department of State (DOS) contract to provide telehealth consult services to DOS medical providers serving U.S. Government (USG) employees and family members posted overseas.

Leveraging Northwell Health’s extensive network of specialists, Northwell Direct will provide consultation services to DOS that will assist its medical staff around the world. DOS providers can request consultations 24 hours a day, 365 days a year that will be triaged and navigated to the appropriate Northwell specialty provider.

“Telemedicine is a unique area of opportunity for Northwell Direct to provide support and expertise to the Department of State,” said Jonathan Berkowitz, MD, medical director of center emergency medical services at Northwell Health. “We are virtually leveraging the collective expertise of our health system in innovative ways. The breadth and depth of services we have across our network, coupled with our advanced telehealth and integrated technology platform, allows us toextend our reach and impact far beyond the traditional borders of the health system and appropriately support the Department of State.”

Additionally, Northwell specialists will also provide support for pre-deployment medical clearances and clinical case reviews.

“Northwell Direct is proud to be working with the United States Department of State and doing our part to ensure that the employees and family members who serve our country have access to the highest quality health care services while serving abroad,” said Nick Stefanizzi, Chief Executive Officer of Northwell Direct. “The broad range of services we have deployed to meet the unique needs of the DOS are representative of the wholistic approach Northwell Direct takes to supportall of its employer clients both domestically and internationally.”

More than 100 specialties across medical, surgical, psychiatry and pediatrics will be made available to DOS providers, with the most consulted specialties including orthopedics, cardiology, radiology, neurosciences, dermatology, and emergency medicine.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

FDA Grants Fast Track Designation to 9MW3011

9MW3011 has been approved to clinical study by NMPA and FDA, respectively. The first person has been dosed in the clinical study in China in March, 2023.

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

"We are pleased to gain the QIDP and Fast Track designations for DFI as recognition that contezolid and contezolid acefosamil are novel new agents to meet an important unmet need in this common and challenging infection", stated Dr Zhengyu Yuan, Chief Executive Officer at MicuRx. 

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) Application for VNT-101

"We look forward to evaluating VNT-101 in the clinic," said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. "This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic."

FDA OK’s ensoETM for Use in Cardiac Ablations to Reduce Risk of Esophageal Injury

Published studies that have examined the use of ensoETM for this purpose include the pilot eCOOL-AF study, the IMPACT study and a large multi-center analysis of over 25,000 patients (in press at the Journal of the American College of Cardiology: Clinical Electrophysiology). These studies have found up to an 83 percent reduction in esophageal injuries, and a significant reduction in risk of atrioesophageal fistula (AEF), one of the most dreaded complications of ablation procedures. Receives FDA Clearance and Breakthrough Device Designation has also received FDA Breakthrough Device Designation for its obstructive hydrocephalus software tool. This is the first radiology triage device to be granted Breakthrough status since the inception of the FDA Breakthrough Devices Program.

By using this website you agree to accept Medical Device News Magazine Privacy Policy